CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement
- 8-K Event Other events
- 8-K Event Other events
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 523 shares (grant or award)
- 4 Grant or award Director acquired 333 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Grant or award Director acquired 1,866 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 7 of 99 · 1,967 filings